The HSF1 Knockout NCI-H1299 Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal knockout cell population derived from NCI-H1299 human lung adenocarcinoma cells. It features targeted disruption of the HSF1 gene encoding heat shock factor 1, the master regulator of the heat shock response. As a polyclonal pool, this population provides a heterogeneous loss-of-function model suitable for studying stress-adaptive pathways without clonal bias. Researchers can employ these cells to dissect HSF1-dependent mechanisms in a disease-relevant background using standard functional assays.
The parental NCI-H1299 cell line is a well-established non-small cell lung cancer (NSCLC) model originating from a lymph node metastasis of a lung adenocarcinoma. These epithelial cells are widely utilized in oncology research to investigate tumor biology, metastatic processes, and therapeutic responses. Their robust growth and molecular characterization make them an excellent platform for gene-editing studies. Knockout of HSF1 in this context enables precise interrogation of proteostasis and stress signaling contributions to lung cancer phenotypes.
HSF1 is the master transcriptional regulator of the heat shock response. Upon stress, it trimerizes, binds heat shock elements, and drives expression of heat shock proteins such as HSP70 (HSPA1A/1B), HSP90 (HSP90AA1/AB1), HSP27 (HSPB1), BAG3, and DNAJB1. Its activity is regulated by upstream kinases (MAPK, AKT, mTOR), deacetylases (SIRT1, HDACs), and chaperone interactions (HSP90, HSP70, HSBP1), integrating proteotoxic signals to promote cell survival.
In NCI-H1299 lung adenocarcinoma cells, HSF1 supports oncogenic proliferation and proteotoxic stress tolerance. Cancer cells often rely on elevated chaperone expression to manage misfolded proteins, and HSF1 disruption abrogates this protective response. The polyclonal knockout model therefore permits investigation of stress-induced cell death, chemosensitivity, and resistance mechanisms. It serves as a powerful tool to evaluate the therapeutic potential of targeting HSF1 in NSCLC and to map stress-adaptive signaling networks that drive cancer progression.
Typical applications include cancer biology, stress response, and drug resistance studies. Researchers can perform viability and apoptosis assays after heat shock or drug treatments, Western blotting for HSP70/HSP90, RT-qPCR for HSF1 targets, ChIP-qPCR to assess promoter occupancy, proteasome activity measurements, and reporter gene assays. This polyclonal population is also suited for complementation studies and high-throughput screens. For further technical information, please contact Ascent Research.
